Reply to Letter Regarding Article, “Evidence That Links Loss of Cyclooxygenase-2 With Increased Asymmetric Dimethylarginine: Novel Explanation of Cardiovascular Side Effects Associated With Anti-Inflammatory Drugs”

File(s)

revised_Reply to Letter to the Editor- Surdacki et al.pdf (42.38 KB)

Accepted version

Show more

Author(s)

Ahmetaj-Shala, B

Kirkby, NS

Knowles, R

Al'Yamani, M

Mazi, S

more

Type

Journal Article

Date Issued

2015-10-27

Date Acceptance

2015-10-01

Citation

Circulation, 2015, 132 (17), pp.E213-E214

URI

http://hdl.handle.net/10044/1/40904

DOI

https://www.dx.doi.org/10.1161/CIRCULATIONAHA.115.017260

ISSN

0009-7322

Publisher

American Heart Association

Start Page

E213

End Page

E214

Journal / Book Title

Circulation

Volume

132

Issue

17

Copyright Statement

© 2015 American Heart Association, Inc.

Sponsor

Wellcome Trust

Grant Number

080429/Z/06/Z

Subjects

Science & Technology

Life Sciences & Biomedicine

Cardiac & Cardiovascular Systems

Peripheral Vascular Disease

Cardiovascular System & Cardiology

Animals

Anti-Inflammatory Agents

Arginine

Cardiovascular Diseases

Cyclooxygenase 2

Cyclooxygenase 2 Inhibitors

Female

Humans

Male

Cardiovascular System & Hematology

1103 Clinical Sciences

1102 Cardiovascular Medicine And Haematology

1117 Public Health And Health Services

Publication Status

Published